The arteriovenous fistula (AVF) is the preferred hemodialysis vascular access, but it is
complicated by high failure rates and attendant morbidity. This study provides the first …

Heme oxygenase-2 (HO-2), the constitutive isoform of the heme-degrading enzyme heme
oxygenase, may serve as an anti-inflammatory vasorelaxant, in part, by generating carbon …

Hemodialysis patients depend on arteriovenous fistulas (AVF) for vascular access.
Unfortunately, their 2-yr primary patency rate is only 60% because of AVF clog due to intimal …

The study of hemodynamic alterations following the creation of an arteriovenous fistula
(AVF) is relevant to vascular adaptive responses and hemodialysis access dysfunction. This …

Background The poor clinical results that are frequently reported for arteriovenous fistulae
(AVF) for hemodialysis are typically due to failure of AVF maturation. We hypothesized that …

Vascular access dysfunction contributes to patient morbidity during maintenance
hemodialysis. In this study we determined if knockout of heme oxygenase-1 predisposed to …

Vascular access failure is a major clinical problem for patients on hemodialysis, but
therapeutic approaches aimed at improving arteriovenous fistula (AVF) dysfunction remain …

Arteriovenous fistulas (AVFs) are usually used for vascular access in the provision of
hemodialysis, but AVFs have a 1-year patency rate of only about 60% owing to stenosis. As …

Key points Patients with end‐stage renal failure need arteriovenous fistulas (AVF) to
undergo dialysis. However, AVFs present a high rate of failure as a result of excessive …

Objective The arteriovenous fistula (AVF) is the preferred method of dialysis access because
of its proven superior long-term outcomes. However, women have lower rates of AVF …